Related Experiment Video
Updated: Apr 18, 2026

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
Cyclo-oxygenase-2 expression in oral squamous cell carcinoma
Maryam Seyedmajidi1, Shahryar Shafaee, Sepideh Siadati
1Department of Oral and Maxillofacial Pathology of Dental Materials Research Center, Dental Faculty, Babol University of Medical Sciences, Babol, Iran.
Cyclooxygenase-2 (COX-2) is highly expressed in oral squamous cell carcinoma (OSCC) and oral dysplasia, supporting its role in oral cancer development and progression. This enzyme is a potential target for oral cancer prevention and treatment.
Area of Science:
- Oncology
- Biochemistry
Background:
- Cyclooxygenase-2 (COX-2) plays a key role in carcinogenesis by synthesizing prostaglandins.
- Experimental models show COX-2 inhibitors can suppress tumor formation, including tongue carcinoma.
Purpose of the Study:
- To investigate the immunohistochemical expression of COX-2 in oral squamous cell carcinoma (OSCC).
- To compare COX-2 expression in OSCC, oral dysplasia, and normal oral mucosa.
Main Methods:
- Immunohistochemical staining for COX-2 expression was performed on 60 tissue samples (20 OSCC, 20 dysplasia, 20 normal mucosa).
- COX-2 immunoreactivity was assessed by quantifying stained cell percentage and intensity.
- Statistical analysis included Kruskal-Wallis, ANOVA, Mann-Whitney tests, with P<0.05 considered significant.
Main Results:
- Significantly higher COX-2 expression was observed in OSCC and oral dysplasia compared to normal oral mucosa.
- A positive correlation exists between COX-2 expression levels and the severity of oral dysplasia.
- No significant difference in COX-2 expression was found between low-grade and high-grade OSCC tumors.
Conclusions:
- The findings support the involvement of COX-2 in oral carcinogenesis.
- COX-2 expression is linked to the progression of premalignant oral lesions to malignancy.
More Related Videos
03:36Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Inhibition of Cdk Activity
Positive Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...